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A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment 
Introduction
Impairment of fertility and toxicity to the developing embryo are the principal endpoints to be determined in regulatory testing for reproductive toxicity. Several internationally accepted Test Guidelines (TG) of the Organisation for Economic Co-operation and Development (OECD) are available for this purpose: TG 414 to detect developmental toxicity, one-and two-generation reproduction studies (TGs 415 and 416) to detect fertility impairment, and combined reproductive/developmental toxicity screening studies (TGs 421 and 422). While the latter offer certain advantages in terms of reduced costs and animal use, their value for hazard assessment is limited by a number of recognized shortcomings [1] . Thus, the revision of TG 415 for use under the European Union (EU) regulation concerning the Registration, Evaluation and Authorisation of Chemicals (REACH) should be seen as an urgent priority [2] . Our new approach for a revised TG 415 is based on the recommendations of the Agricultural Chemical Safety Assessment (ACSA) Technical Committee of the ILSI Health and Environmental Sciences Institute (HESI) for a new extended one-generation study to be used for pesticide testing [3] (Fig. 1 ) and on an initiative by the German Federal Institute for Risk Assessment (BfR) for an update of the existing TG 415 for chemicals testing under the new EU chemicals legislation REACH. Although originally submitted to the OECD as separate projects, these initiatives have since been merged, and a single draft TG for an extended onegeneration study is currently under discussion by OECD expert groups. The following presentation is intended to contribute to this international initiative, and in particular, to support the establishment of an OECD TG based on a new streamlined one-generation study that will yield reliable results for classification and labelling of chemicals, but which may also be extended to include one or more modules as a means of gathering needed data as efficiently and economically as possible. 
Added value of a second generation
A number of retrospective analyses of multigenerational studies have cast doubt upon the longstanding assumption that the production of at least two generations of offspring is necessary for the accurate identification of reproductive toxicants and dose response characterization. For instance:
 A review of approximately 300 pesticide multigenerational studies in the US "SABRE" database revealed that for only two substances would adverse effects not have been detected based on F1 results or other available toxicology data [1] . A detailed publication of these findings is anticipated in the near future.  The Dutch National Health Authority (RIVM) conducted a retrospective study on 176 multigenerational studies that had been submitted to EU and US authorities [4] . In the twogeneration studies, the effects reported in F2 animals did not affect the overall NOAEL. It was therefore concluded that the two-generation study impacted neither risk assessment nor classification and labelling.  A review of 22 two-generation studies identified three studies in which effects were confined exclusively to the second generation. However, applying the triggers proposed by HESI-ACSA revealed that all three studies would have been extended to the second generation [3, 5] .
The above examples illustrate that, almost without exception, F2 data do not contribute essential information for risk assessment and regulation beyond what can be gleaned from F1 results, and that in the handful of instances where this is not the case, F1 results would reliably trigger an extension to a second generation. It is essential, that the possibility of omitting a second generation will not impair the safety of consumers and workers. Therefore, all available data from two-generation studies will be analysed once again retrospectively and assessed by using standardized criteria. As a result, it is expected that a routine requirement to conduct two-generation studies should be discontinued in favour of a flexible testing strategy based on a one-generation study.
Proposed new test design

Standard test
Given the range of potential regulatory applications of an enhanced one-generation study, we recommend that the core design be limited to a one-generation study according to the OECD TG415. This study should be updated in thewaythe two-generation study (OECD TG 416) was updated several years ago. Additional modules may be included to this updated one-generation study depending on triggers and/or sector-specific requirements (Fig. 2) . Based on intensive discussions concerning triggering and waiving criteria at an April 2008 expert workshop co-organised by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) and the European Centre for the Validation of Alternative Methods (ECVAM) [6] , at which participants could not reach agreement on reliable criteria for waiving a module, we do not believe that an all-encompassing, waiver-based approach is feasible in current regulatory practice. Therefore, we provide guidance to trigger modules which could be added to the core study.
Triggered second mating or second generation module
If unequivocal positive or negative findings on fertility parameters were obtained from the standard test, no further testing would be necessary. Equivocal results, however, could lead to a more detailed evaluation of a second litter or to a second generation (Fig. 2) . This type of flexible approach is already standard practice [7] . To produce a second generation, F1 pups could be selected and processed as described in TG 416.
Triggered developmental toxicity module (OECD TG 414 rat)
We propose that clear evidence of adverse effects upon structural development in the enhanced onegeneration study should permit classification and labelling without further testing. Likewise, if data are clearly negative, further testing would be unlikely to influence a classification or risk assessment decision, since it is improbable that a signal that an agent is a developmental toxicant would be completely overlooked when the entire F1-generation is analysed. However, equivocal results could trigger a prenatal developmental toxicity module or a stand-alone TG 414 study (Fig. 2) . 
Triggered developmental neurotoxicity module (OECD TG 426)
Testing for developmental neurotoxicity (DNT) is not a legal requirement in Europe either for pesticides or other chemical substances; in fact, a category for the classification and labelling of neurotoxicants does not currently exist in the EU. On the other hand, developmental neurotoxic effects could possibly be integrated into a common category "reproductive toxicant". In the US, DNT testing has recently been codified as a conditional data requirement for the registration of conventional pesticides, although published evidence suggests that DNT data seldom afford additional or increased human health protection beyond what is achieved by assessing risks from more conventional toxicity studies. This was evident from a US EPA retrospective review of 12 organophosphate pesticides [8] , as well as a more recent HESI survey of 113 reproduction studies of pharmaceutical compounds that included behavioural assessment of F1 animals, which revealed that in only 2.6% of cases did DNT data alone define the noeffect level [9] . These are of course preliminary findings, which must be confirmed by a broader database. Nevertheless, an even lower percentage could be expected for industrial chemicals or other nonbiologically active substances.
Evidence to date does not support the inclusion of DNT as a routine information requirement or as a default module in an enhanced one-generation study. However, in cases where a study according to TG 426 would otherwise be carried out as a stand-alone according to a regulatory requirement and/or external trigger [10] , it would be preferable for such an evaluation to occur as a module to a onegeneration study (Fig. 2) . Nevertheless it is still open to discussion in which way the results of such studies can be used for classification and labelling under REACH and the GHS.
Triggered developmental immunotoxicity (OECD TG not existing)
Cooper et al. [3] also proposed the inclusion of amodule to evaluate developmental immunotoxicity (DIT) (Fig. 1) . However, we believe it is premature to include a DIT module in the enhanced one-generation TG for the following reasons  No regulatory data requirement for DIT exists anywhere in the world, and only a handful of ad hoc "special studies" have been requested to date.  Only recently has one pesticide regulator codified a requirement for an adult immunotoxicity study, so no contribution can be claimed to further international harmonization of hazard and risk assessment approaches.  No standardized or validated methodology or OECD TG currently exists for the evaluation of immunotoxicity in either adult or developing animals, although discussions among experts have taken place [11] .  Although an enhanced one-generation study would be suited for general use, DIT data are of dubious relevance outside the pesticides sector.
This perspective was shared by a majority of participants at the April 2008 ECETOC-ECVAM expert workshop [6] .
Validation
When OECD TG 414, 415 and 416 were introduced in 1982, the tests were not formally validated with respect to their reliability or relevance for the human situation. However, after many years of practical experience, they are generally regarded as valid by regulatory authorities. The proposed modular onegeneration study is based on aspects of these TGs and does not involve new endpoints. Therefore, a formal validation should not be required for the core reproduction study, including the extensions to a second litter/generation, as well as for the prenatal developmental and DNT modules.
The practicability of the new approach is currently under investigation in a joint feasibility project between the European Partnership on Alternative Approaches to Animal Testing (EPAA) and the US EPA.
Implementation and triggers
